Examination of the Effective Utilization of the CARELINK® Remote Monitoring System after its Introduction

  • Miyamoto Satoshi
    Division of Clinical Engineering, Clinical Support Department, Hiroshima University Hospital
  • Nakano Yukiko
    Department of Cardiovascular Medicine, Hiroshima University Hospital
  • Okahara Shigeyuki
    Division of Clinical Engineering, Clinical Support Department, Hiroshima University Hospital
  • Takahashi Hidenobu
    Division of Clinical Engineering, Clinical Support Department, Hiroshima University Hospital
  • Matsuzaki Hisayasu
    Division of Clinical Engineering, Clinical Support Department, Hiroshima University Hospital
  • Oda Noboru
    Department of Cardiovascular Medicine, Hiroshima University Hospital
  • Imai Katsuhiko
    Department of Cardiovascular Surgery, Hiroshima University Hospital
  • Sueda Taijirou
    Department of Cardiovascular Surgery, Hiroshima University Hospital
  • Kihara Yasuki
    Department of Cardiovascular Medicine, Hiroshima University Hospital

書誌事項

タイトル別名
  • Examination of the Effective Utilization of the CARELINK Remote Monitoring System after its Introduction

この論文をさがす

抄録

Background: Japan started using the CARELINK® (Medtronic, Inc, Minneapolis, MN, USA) remote monitoring system in April 2009. However, in some cases, the device failed to transmit a message after registration or according to schedule. We investigated the difference between patients who could make effective use of CARELINK® system and those who could not.<BR>Subjects and Method: Sixty patients who had registered until December 2009 at our institution were analyzed. These patients were divided into two groups: those who were able to use the device effectively (group G, n=49) and those who were not (group F=11). Patient background, automatic or manual telemetries, new or existing implant patient, presence of adverse events, and the use or non-use of a checklist at the time of introduction were compared between the two groups.<BR>Results: In group G, more patients used a checklist at the time of introduction than that in group F (use of checklist/total, 31/49 in group G vs. 3/11 in group F; P, 0.029). No significant difference was observed in other factors between the two groups.<BR>Conclusion: We consider that the method used to explain the system are important to make the patients understand handling methods of CARELINK® system. The number of patients introduced to remote monitoring of implantable devices will continue to increase in the future; therefore, we must continue to develop innovative approaches for their effective use.

収録刊行物

参考文献 (33)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ